Assurity Names Draper Daniel Vice President, Customer Connections
Daniel brings more than 28 years of insurance industry experience to the role, with a background in operational leadership and business transformation. He has previously led large customer service organizations and high-performing leadership teams, and has deep experience in improving and transforming operations.
"Draper's passion for developing people and leaders is a strong fit for our culture of continuous improvement," says
Daniel says Assurity's commitment to its customers helped him make his decision. "I was drawn to Assurity because of its commitment to its customers, employees and the community," he says. "Customer service is the backbone of an organization. It's where we have the opportunity every day to deliver on the promises we make to our customers."
Daniel graduated from Doane University with a Bachelor of Science in Business Management. He lives in
Assurity - Protecting What Matters Most
At Assurity, insurance has always been about people first. Since 1890, our financial strength and steady purpose have been a constant in a changing world. As a mutual organization and Certified B Corporation, we're built to serve, rooted in the simple idea that doing good is good business.
Our mission of helping people through difficult times guides everything we do. We stand beside people balancing it all – jobs, families, dreams, and responsibilities.
When the ground shifts, we're here for what matters most. Because life is full of milestones and moments worth protecting.
View original content to download multimedia:https://www.prnewswire.com/news-releases/assurity-names-draper-daniel-vice-president-customer-connections-302893216.html
SOURCE Assurity
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beyond Now launches agentic platform to power CSPs growth in the agentic economy
- Financial Wellness Programs Have a Heftier Price Tag when Built In-House, New Research Finds
- Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Tech
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share